Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3Vasculitis 1Neoplasms 1Lupus Erythematosus, Systemic 1Leukemia, Myeloid, Acute 1Glomerulonephritis 1Colorectal Neoplasms 1Colonic Neoplasms 1COVID-19 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 112Fluorouracil 104Leucovorin 91Irinotecan 91Capecitabine 59Bevacizumab 58Cetuximab 46Folfox protocol 28Colonoscopy 24Panitumumab 19Chemotherapy, Adjuvant 19Blood Specimen Collection 19Drug Therapy 18Nivolumab 17Magnetic Resonance Spectroscopy 17Radiotherapy 16Exercise 16Early Intervention, Educational 16Surveys and Questionnaires 15Laparoscopy 15Surgical Procedures, Operative 13Floxuridine 13Biopsy 13trifluridine tipiracil drug combination 12pembrolizumab 12XELOX 12Neoadjuvant Therapy 11Methods 11Immunohistochemistry 11Celecoxib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colonic Neoplasms × Niclosamide × Clear all
NCT02687009 2020-02-19

A Study of Niclosamide in Patients With Resectable Colon Cancer

Duke University

Phase 1 Terminated
1 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡